Drug maker Krka's group net profit down 28% in Jan-Jun
Novo Mesto, 6 July - The group around drug company Krka reported an estimated net profit of EUR 170 million for the first half of 2023, a 28% year-on-year decrease that the company attributed to high foreign exchange gains in 2022. Revenue grew by 7% to EUR 920 million and operating profit (EBIT) by 9% to a six-month company record of EUR 236 million.
Novo mesto
Pharma company Krka logo
Photo: Rasto Božič/STA
File photo
The rest of this news item is available to subscribers.
The news item consists of 1.630 characters (without spaces) or 331 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.